Guidance for industry [[electronic resource] ] : listed drugs, 30 month stays, and approval of ANDAs and 505(b)(2) applications under Hatch-Waxman, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, questions and answers
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Guidance for industry [[electronic resource] ] : listed drugs, 30 month stays, and approval of ANDAs and 505(b)(2) applications under Hatch-Waxman, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, questions and answers
|
| Pubblicazione: | Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, , [2004] |
| Descrizione fisica: | 1 online resource (12 pages) |
| Soggetto topico: | Drug approval - United States |
| Note generali: | "Draft guidance." |
| "OGD." | |
| "October 2004." | |
| Altri titoli varianti: | Guidance for industry |
| Titolo autorizzato: | Guidance for industry |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910699281003321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |